Preliminary results from an interim analysis of clinical trials of the ChAdOx1 nCoV-19 candidate show the Vaccine is on average 70.4% Effective at preventing Covid-19. Data was taken from two dosing regimes, which show that the vaccine is 90% effective when administered at a half dose followed by a full dose, or 62% effective when […]

The post Oxford & AstraZeneca Covid-19 vaccine up to 90% effective, data shows first appeared on World Pharma Today.